Aug 20 |
Johnson & Johnson Strikes $1.7B Deal To Acquire Heart-Tech Innovator V-Wave
|
Aug 20 |
J&J drug combo for lung cancer approved by FDA
|
Aug 20 |
AstraZeneca Is a Cancer Leader. Obesity Could Be a Bonus.
|
Aug 19 |
Daiichi Sankyo-AstraZeneca’s ENHERTU gains BTD for breast cancer
|
Aug 16 |
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
|
Aug 16 |
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer
|
Aug 16 |
AstraZeneca wins approval for Imfinzi in NSCLC perioperative setting
|
Aug 16 |
Pharma Stock Roundup: AZN Gets Approvals for Imfinzi Expanded Use, MRK Inks New Deal
|
Aug 16 |
FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer
|
Aug 16 |
AstraZeneca Imfinzi label expanded in U.S. for lung cancer
|